The cell lines were obtained from ATTC (Manassas, VA, USA). HeLa (human cervix epithelioid carcinoma),
MCF7 (human breast adenocarcinoma),
HepG2 (human hepatocellular carcinoma),
U87 MG (human glioblastoma), T98G (human glioblastoma),
GL261 (murine glioma),
LNCaP (human prostate cancer), PC-3 (human prostate cancer), and
HEK-293 (human embryonic kidney) were grown in Dulbecco’s modified Eagle’s medium (
DMEM, Gibco, Waltham, MA, USA), supplemented with 10% (
v/
v) heat-inactivated fetal bovine serum (
HIFBS, Sigma-Aldrich, St. Louis, MO, USA)), 2 mM L-glutamine, 100 μg/mL
streptomycin, and 100 units/mL
penicillin (Gibco, Waltham, MA, USA) at 37 °C in saturated humidity atmosphere containing 95% air and 5% CO
2. Cell line HT-29 (human colon carcinoma) was grown in Roswell Park Memorial Institute (
RPMI) 1640 medium (Gibco, Whaltman, MA, USA) supplemented with 10%
HIFBS, 100 μg/mL
streptomycin, and 100 units/mL
penicillin (Gibco, Whaltman, MA, USA) at 37 °C in humidified 95% air and 5% CO
2 atmosphere.
MycoAlert kit (Lonza, Norwest, Australia) was used to routinely check the presence of mycoplasma, and only mycoplasma-free cells were employed in the experiments.
Gallego-Yerga L., Ceña V, & Peláez R. (2023). Potent and Selective Benzothiazole-Based Antimitotics with Improved Water Solubility: Design, Synthesis, and Evaluation as Novel Anticancer Agents. Pharmaceutics, 15(6), 1698.